Sexual arousal suppression

Sexual arousal suppression is a reduction or complete absence of sexual interest and physical arousal that occurs during acute intoxication.

As a drug effect it is dose-proportional and transient, fading as the substance wears off, which sets it apart from clinical hypoactive sexual desire disorder. It ranges from mild blunting of libido to the near-total absence of arousal or capacity for physical response.

The effect is commonly reported across several major drug classes. It is most frequently induced at moderate to high doses under stimulants such as amphetamine, MDMA, and cocaine, and under opioids such as heroin, fentanyl, and codeine. It also appears at higher doses under depressants like alcohol, GHB, and baclofen, and under dissociatives such as ketamine and dextromethorphan.

Sexual arousal suppression is felt as a flattening of erotic interest: thoughts that would ordinarily kindle desire simply do not catch, and familiar stimuli register as neutral rather than arousing.

Physical correlates include reduced genital sensitivity, an absence of spontaneous arousal, and a general bodily disengagement — the body present but muted. Attending to the absence tends to confirm it; trying to force arousal only deepens awareness that it is not there. At higher doses, particularly under opioids, the suppression can be near-complete, extending into a broad indifference toward sexuality.

Sexual arousal suppression arises through different pathways depending on the drug class:

• Stimulants — redirect dopaminergic and noradrenergic activity toward competing arousal states and produce vascular constriction that limits physical response.
• Opioids — suppress gonadotropin-releasing hormone signaling, acutely blunting both drive and physical responsiveness.
• Depressants — at high doses, broadly reduce CNS excitability and autonomic tone, impairing the physiological arousal sexual response requires.
• Dissociatives — produce a disconnect from bodily sensation that makes physical arousal difficult to register or sustain.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses increase both likelihood and severity across all associated classes. Set and setting matter — particularly under dissociatives, where disconnection from interoceptive sensation tracks closely with dose and context.

Disposition plays a role: those with lower baseline libido or prior history of sexual difficulty tend to notice the effect more readily. Expectation can amplify it — anticipating suppression sharpens awareness of it. At low doses, especially under depressants, the effect is often absent entirely.